Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Turgay Celık

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Cardiology|September 8, 2009
Reduced left ventricular ejection fraction and sudden cardiac death in patients undergoing revascularization: time to remember the other players of the gameTurgay Celık, M İlker Yılmaz, Ergun Ucar, et al.
Cardiology Journal|October 28, 2015
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary interventionTurgay Celık, Sevket Balta, Mustafa Demır, et al.
Blood Pressure|November 13, 2014
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartanTurgay Celık, Sevket Balta, Murat Karaman, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Cardiology|September 8, 2009
Reduced left ventricular ejection fraction and sudden cardiac death in patients undergoing revascularization: time to remember the other players of the gameTurgay Celık, M İlker Yılmaz, Ergun Ucar, et al.
Cardiology Journal|October 28, 2015
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary interventionTurgay Celık, Sevket Balta, Mustafa Demır, et al.
Blood Pressure|November 13, 2014
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartanTurgay Celık, Sevket Balta, Murat Karaman, et al.
Pageof 1